Administration Of Control-released Basic Fibroblast Growth Factor—Is It A More Effective Angiogenic Therapy Than Bone Marrow Cell Transplantation For Severely Ischemic Hearts?

https://doi.org/10.1016/j.ics.2003.11.046

10.1016/j.ics.2003.11.046 复制